Role of nitric oxide synthase inhibition in the acute hypertensive response to intracerebroventricular cadmium

British Journal of Pharmacology

Volumn 123, Issue 1, 1998, Pages 129-135

  Demontis, Maria Piera ^a   Varoni, Maria Vittoria ^a   Volpe, Anna Rita ^d   Emanueli, Costanza ^c   Madeddu, Paolo ^a,b,e  

^a UNIVERSITY OF SASSARI   (Italy)

^b NATIONAL INSTITUTE OF BIOSTRUCTURES AND BIOSYSTEMS   (Italy)

^c UNIVERSITY OF FERRARA   (Italy)

^d CATHOLIC UNIVERSITY   (Italy)

^e Clinica Medica   (Italy)

Author keywords

Blood pressure; Calcium; Central nervous system; Heavy metals; Nitric oxide synthase

Indexed keywords

ARGININE; CADMIUM; CALCIUM CHLORIDE; CITRULLINE; LINSIDOMINE; N ACETYL S NITROSOPENICILLAMINE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN; BRAIN CORTEX; CARDIOVASCULAR FUNCTION; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; CYTOSOL; ENZYME INHIBITION; HALF LIFE TIME; HIPPOCAMPUS; HYPERTENSION; HYPOTHALAMUS; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; MALE; NONHUMAN; PONS; PRESSOR RESPONSE; PRIORITY JOURNAL; PROTEIN CONTENT; RAT; STRIATE CORTEX;

ANIMALS; ARGININE; BLOOD PRESSURE; BRAIN CHEMISTRY; CADMIUM; CALCIUM CHLORIDE; CITRULLINE; ENZYME INHIBITORS; HEART RATE; HYPERTENSION; INJECTIONS, INTRAVENTRICULAR; MALE; MOLSIDOMINE; NITRIC OXIDE SYNTHASE; PENICILLAMINE; RATS; RATS, WISTAR; S-NITROSO-N-ACETYLPENICILLAMINE; VASODILATOR AGENTS;

EID: 6844242312     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0701573     Document Type: Article

References (27)

1. BALARAMAN, R., GULATI, O.D. & BHATT, J.D. (1989). Cadmium-induced hypertension in rats. Pharmacology, 38, 226-234.
2. BREDT, D.S., HWANG, P.M. & SNYDER, S.H. (1990). Localization of nitric oxide synthase indicating a neural role for nitric oxide. Nature, 347, 768-770.
3. CABRERA, C.L. & BHOR, D.F. (1993). The role of nitric oxide in the central control of blood pressure. Biochem. Biophys. Res. Commun., 206, 77-81.
4. CHEUNG, W. (1984). Calmodulin: its potential role in cell proliferation and heavy metal toxicity. Fedn. Proc., 43, 2995-2999.
5. CURRȮ, D., VOLPE, A.R. & PREZIOSI, P. (1996). Nitric oxide synthase activity and non-adrenergic non-cholinergic relaxation in the rat gastric fundus. Br. J. Pharmacol., 117, 717-723.
6. DOMINICZAK, A.F. & BOHR, D.F. (1995). Nitric oxide and its putative role in hypertension. Hypertension, 25, 1202-1211.
7. w-nitro-L-arginine) on blood pressure and plasma renin. Clin. Exp. Hypertens., 15, 819-832.
8. FONTANA, S.A. & BOULOS, B.M. (1988). Blood cadmium level as affected by hypertension, smoking, occupation and body mass. Am. J. Hypertens., 1, S158-S160.
9. GLAUSER, S.C., BELLO, C.T. & GLAUSER, E.M. (1976). Blood cadmium levels in normotensive and untreated hypertensive humans. Lancet, i, 717-718.
10. ++ in calmodulin. Arch. Toxicol., 323, 31-46.
11. HARADA, S., TOKUNAGA, S., MOMOHARA, M., MASAKI, H., TAGAWA, T., IMAIZUMI, T. & TAKESHITA, A. (1993). Inhibition of nitric oxide formation in the nucleus tractus solitarius increases renal sympathetic nerve activity in rabbits. Circ. Res., 72, 511-516.
12. HECKER, M., SESSA, W.C., HARRIS, H.J., ANGGARD, E.E. & VANE, J.R. (1990). The metabolism of L-arginine and its significance for the biosynthesis of endothelium-derived relaxing factor: Cultured endothelial cells recycle L-citrulline to L-arginine. Proc. Natl. Acad. Sci. U.S.A., 87, 8612-8616.
13. JOSHI, P. & DESAIAH, D. (1994). Inhibition of nitric oxide synthase activity in rat brain by metals. Toxicologist, 14, 198.
14. KNOWLES, R.G., PALACIOS, M., PALMER, R.M.J. & MONCADA, S. (1989). Formation of nitric oxide from L-arginine in the central nervous system: a transduction mechanism for stimulation of the soluble guanylate cyclase. Proc. Natl. Acad. Sci. U.S.A., 86, 5159-5162.
15. KRUKOFF, T.L., GEHLEN, F., GANTEN, D. & WAGNER, J. (1995). Gene expression of brain oxide synthase and soluble guanylyl cyclase in hypothalamus and medulla of two-kidney, one clip hypertensive rats. Hypertension, 25, 171-176.
16. MADEDDU, P., DEMONTIS, M.P., VARONI, M.V., FATTACCIO, M.C., PALMIERI, A. & ANANIA, V. (1993). Verapamil prevents the acute hypertensive response to intracerebroventricular cadmium in conscious normotensive rats. Am. J. Hypertens., 6, 193-197.
17. MITTAL, C.K., HARREL, W.B. & MEHTA, C.S. (1995). Interaction of heavy metals toxicants with brain constitutive nitric oxide synthase. Mol. Cell. Biochem., 149/150, 263-265.
18. NORDBERG, M. (1984). General aspects of cadmium: transport, uptake and metabolism by the kidney. Environ. Health Perspect, 54, 13-20.
19. PERRY, H.M., ERLANGER, M.W. & PERRY, E.F. (1977). Elevated systolic pressure following chronic low level cadmium feeding. Am. J. Phyiol., 232, H114-H121.
20. REVIS, N. (1977). A possible mechanism for cadmium induced hypertension in rats. Life Sci., 22, 479-488.
21. STAESSEN, J. & LAUWERYS, R. (1993). Health effects of environmental exposure to cadmium in a population study. J. Human Hypertens, 7, 195-199.
22. ++ movements in synaptosomes and subcellular fractions from rat brain and torpedo electric organ. Brain Res., 323, 31-46.
23. TEMPLETON, D.M. & CHERIAN, G.M. (1983). Cadmium and hypertension. Trends Pharmacol. Sci., 4, 501-503.
24. TODA, N., KITAMURA, Y. & OKAMURA, T. (1993). Neural mechanism of hypertension by nitric oxide synthase inhibitor in dogs. Hypertension, 2, 13-18.
25. TOGASHI, H., SAKUMA, I., YOSHIOKA, M., KOBAYASHI, T., YASUDA, H., KITABATAKE, A., SAITO, H., GROSS, S.S. & LEVI, R. (1992). A central nervous system action of nitric oxide in blood pressure regulation. J. Pharmacol. Exp. Ther., 262, 343-347.
26. TSENG, C.J., LIU, H.Y., LIN, H.C., GER, L.P., TUNG, C.S. & YEN, M.H. (1996). Cardiovascular effects of nitric oxide in the brain stem nuclei of rats. Hypertension, 27, 36-42.
27. WHITTEMORE, A.S., DICICCIO, Y. & PROVENZANO, G. (1991). Urinary cadmium and blood pressure: results from the NHANES II Survey. Environ. Health Perspect, 91, 133-140.